Kathryn A Wyman-Chick1,2,3, Phillip K Martin4, Daniel Weintraub5,6, Scott A Sperling3, Lauren O Erickson2, Carol A Manning3, Matthew J Barrett3. 1. HealthPartners Neuroscience Center, Saint Paul, MN. 2. HealthPartners Institute, Bloomington, MN. 3. University of Virginia, Department of Neurology, Charlottesville, VA. 4. University of Kansas School of Medicine-Wichita, Department of Psychiatry and Behavioral Sciences, Wichita, KS. 5. Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 6. Parkinson's Disease and Mental Illness Research, Education and Clinical Centres, Philadelphia Veterans Affairs Medical Centre, Philadelphia, PA.
Abstract
OBJECTIVE: The objective of this study was to examine the impact of different methods of standardizing cognitive data in the Parkinson's Progression Marker Initiative. METHODS: Cognitive data from 423 participants with Parkinson's disease were included (age = 61.7 [9.7], education = 15.6 [3.0]). Internal norms were calculated using the group mean and standard deviation of the healthy control group. Published norms were compared to the overall group mean of and to age-stratified norms from healthy controls for each neuropsychological test over 4 visits. Rates of mild cognitive impairment were calculated using established criteria. RESULTS: The use of internal norms resulted in lower standardized scores than published norms on all tests with the exception of memory and processing speed (P ≤ .001). Individuals were 1.5 to 2.1 times more likely to be diagnosed with mild cognitive impairment using internal norms than published norms. CONCLUSIONS: Standardization approaches with cognitive data are not interchangeable. Selection of a normative comparison group impacts research and clinical interpretations of cognitive data.
OBJECTIVE: The objective of this study was to examine the impact of different methods of standardizing cognitive data in the Parkinson's Progression Marker Initiative. METHODS: Cognitive data from 423 participants with Parkinson's disease were included (age = 61.7 [9.7], education = 15.6 [3.0]). Internal norms were calculated using the group mean and standard deviation of the healthy control group. Published norms were compared to the overall group mean of and to age-stratified norms from healthy controls for each neuropsychological test over 4 visits. Rates of mild cognitive impairment were calculated using established criteria. RESULTS: The use of internal norms resulted in lower standardized scores than published norms on all tests with the exception of memory and processing speed (P ≤ .001). Individuals were 1.5 to 2.1 times more likely to be diagnosed with mild cognitive impairment using internal norms than published norms. CONCLUSIONS: Standardization approaches with cognitive data are not interchangeable. Selection of a normative comparison group impacts research and clinical interpretations of cognitive data.
Authors: Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre Journal: Mov Disord Date: 2012-01-24 Impact factor: 10.338
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: L M Chahine; S X Xie; T Simuni; B Tran; R Postuma; A Amara; W H Oertel; A Iranzo; C Scordia; M Fullard; C Linder; R Purri; A Darin; L Rennert; A Videnovic; P Del Riva; D Weintraub Journal: Parkinsonism Relat Disord Date: 2016-03-12 Impact factor: 4.891
Authors: Daniel Weintraub; Tanya Simuni; Chelsea Caspell-Garcia; Christopher Coffey; Shirley Lasch; Andrew Siderowf; Dag Aarsland; Paolo Barone; David Burn; Lama M Chahine; Jamie Eberling; Alberto J Espay; Eric D Foster; James B Leverenz; Irene Litvan; Irene Richard; Matthew D Troyer; Keith A Hawkins Journal: Mov Disord Date: 2015-03-04 Impact factor: 10.338
Authors: Joana B Pereira; Per Svenningsson; Daniel Weintraub; Kolbjørn Brønnick; Alexander Lebedev; Eric Westman; Dag Aarsland Journal: Neurology Date: 2014-05-07 Impact factor: 9.910
Authors: Mark W Bondi; Wes S Houston; David P Salmon; Jody Corey-Bloom; Robert Katzman; Leon J Thal; Dean C Delis Journal: J Int Neuropsychol Soc Date: 2003-07 Impact factor: 2.892
Authors: Manuel Menéndez-González; Tania Álvarez-Avellón; José M Salas-Pacheco; Benito de Celis-Alonso; Kathryn A Wyman-Chick; Oscar Arias-Carrión Journal: Front Neurol Date: 2018-05-24 Impact factor: 4.003
Authors: Megan C Bakeberg; Anastazja M Gorecki; Abigail L Pfaff; Madison E Hoes; Sulev Kõks; P Anthony Akkari; Frank L Mastaglia; Ryan S Anderton Journal: NPJ Parkinsons Dis Date: 2021-07-07
Authors: Kathryn A Wyman-Chick; Lauren R O'Keefe; Daniel Weintraub; Melissa J Armstrong; Michael Rosenbloom; Phillip K Martin; Terry R Barclay; Matthew J Barrett Journal: J Geriatr Psychiatry Neurol Date: 2021-06-11 Impact factor: 2.718